How digital innovation is helping therapeutics to get to market faster
Drug Discovery World
FEBRUARY 6, 2024
The company has created a novel AI platform to develop enzymes from bacteria-killing viruses (bacteriophages) as a new way to tackle bacterial infections, and has secured €4 million investment to support its development. In June 2023, lab automation company Opentrons launched its Flex robots for scientists using generative AI.
Let's personalize your content